R. Erdem Erkul

Cerebrum Tech made its debut in the world of mobile applications with Cere, a virtual character powered by artificial intelligence

Retrieved on: 
Friday, March 24, 2023

Utilizing a deep learning-based language model, Cere allows mobile phone users to communicate through both text and voice.

Key Points: 
  • Utilizing a deep learning-based language model, Cere allows mobile phone users to communicate through both text and voice.
  • As a highly empathetic language model, Cere is the first-of-its-kind, showcasing the company's commitment to developing innovative mobile applications that enhance the user experience.
  • With its user-friendly mobile application, Cere empowers users to effortlessly integrate the power of artificial intelligence into both their personal and professional lives."
  • Cerebrum Tech, a forward-thinking technology company focused on developing sustainable web3 ecosystems, has announced the launch of its latest creation - the artificial intelligence chat robot, Cere.

Cerebrum Tech made its debut in the world of mobile applications with Cere, a virtual character powered by artificial intelligence

Retrieved on: 
Friday, March 24, 2023

Utilizing a deep learning-based language model, Cere allows mobile phone users to communicate through both text and voice.

Key Points: 
  • Utilizing a deep learning-based language model, Cere allows mobile phone users to communicate through both text and voice.
  • As a highly empathetic language model, Cere is the first-of-its-kind, showcasing the company's commitment to developing innovative mobile applications that enhance the user experience.
  • With its user-friendly mobile application, Cere empowers users to effortlessly integrate the power of artificial intelligence into both their personal and professional lives."
  • Cerebrum Tech, a forward-thinking technology company focused on developing sustainable web3 ecosystems, has announced the launch of its latest creation - the artificial intelligence chat robot, Cere.

Kernal Biologics Announces Presentations at The International mRNA Health Conference

Retrieved on: 
Wednesday, November 9, 2022

CAMBRIDGE, Mass., Nov. 9, 2022 /PRNewswire/ -- Kernal Biologics, Inc. (Kernal Bio) — a development-stage mRNA-technology company developing cancer therapeutics designed to improve patients' survival rate and quality of life — today announced it will have three presentations at the International mRNA Health Conference being held in Boston and virtually from November 8th to 10th, 2022.   

Key Points: 
  • "We are delighted to present our work at this year's International mRNA Health Conference.
  • "In a preclinical study of KR-335, our tumor-selective mRNA LNP, we demonstrate tumor regression, improved overall survival and complete responses across different murine tumor models as a monotherapy."
  • "When expanding into therapeutic modalities, like cancer, universal translation of mRNA may become harmful.In another presentation, we demonstrate how it's possible to develop mRNA 2.0 - novel mRNA therapies using engineered mRNA molecules to translate in specific tissues and cell types.
  • Kernal Bio established a machine learning-backed computational pipeline to analyze transcriptome and translatome datasets across cell types and disease state to discover cell-specific mRNA sequence features.